Patent · US Active

Neoseptins: small molecule adjuvants

US9649373B2 · kind B2 · utility

1Cited by

2References

14Claims

0Family size

Assignees

The Scripps Institute · US
The Board of Regents of the University of Texas System · US

Inventors

Bruce Beutler · Dallas, US
Dale L. Boger

Key dates

Filing date	Feb 25, 2014
Grant date	May 16, 2017
Priority date	—
Expiry date	Feb 25, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C237/44
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A MD-2:TLR4 complex agonist compound is disclosed whose structure corresponds to Formula (I), as defined within. Also disclosed are a method of its preparation and use, as well as a pharmaceutical composition containing the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.